Tag: Danielle Kim Turgeon
PvP Biologics initiates Kuma062 human trials for celiac disease treatment
PvP Biologics, a US pharma company, has initiated two phase 1 clinical trials for Kuma062 to evaluate the recombinant enzyme for celiac disease treatment. According ... Read More